Uterine cancer in breast cancer survivors: a systematic review Akemi T. WijayabahuKathleen M. EganLusine Yaghjyan Review 02 January 2020 Pages: 1 - 19
Cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer: a meta-analysis of randomized clinical trials Jing LiFangmeng FuChuan Wang Review 22 January 2020 Pages: 21 - 32
Healthcare system distrust and the breast cancer continuum of care Morgane C. MouslimRenee M. JohnsonLorraine T. Dean Review 25 January 2020 Pages: 33 - 44
Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells Seung-Su KimMin-Ho LeeMi-Ock Lee Preclinical study Open access 02 January 2020 Pages: 45 - 54
Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease Sabina AdhikaryTanya L. HoskinAmy C. Degnim Preclinical Study Open access 13 January 2020 Pages: 55 - 61
Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics Ellen BjerkesetKari RöhrlInger Schou-Bredal Preclinical study Open access 14 January 2020 Pages: 63 - 71
MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes Elise KlæstadSigne OpdahlMarit Valla Preclinical study Open access 16 January 2020 Pages: 73 - 86
Squamous cell carcinoma of the breast, are there two entities with distinct prognosis? A series of 39 patients F. PirotD. ChaltielA. Conversano Preclinical study 22 January 2020 Pages: 87 - 95
Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling Ayako KanaiKeely May McNamaraHironobu Sasano Preclinical study 27 January 2020 Pages: 97 - 110
Double reading of diffusion-weighted magnetic resonance imaging for breast cancer detection Anna RotiliRubina Manuela TrimboliFrancesco Sardanelli Clinical trial 14 January 2020 Pages: 111 - 120
Effectiveness of adjuvant supportive-expressive group therapy for breast cancer Zeng Jie YeZhang ZhangYuan Liang Yu Clinical trial 16 January 2020 Pages: 121 - 134
A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer Norikazu MasudaShoichiro OhtaniMasakazu Toi Clinical trial Open access 17 January 2020 Pages: 135 - 146
Systemic therapy following craniotomy in patients with a solitary breast cancer brain metastasis Alexander F. C. HulsbergenLogan D. ChoNancy U. Lin Clinical trial Open access 17 January 2020 Pages: 147 - 155
Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen Cristina FerrarisBarbara BallestraGabriele Martelli Clinical trial 24 January 2020 Pages: 157 - 165
The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer Jana de BonifaceJohan Ahlgrenthe SENOMAC Trialists’ Group Clinical trial Open access 27 January 2020 Pages: 167 - 176
Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients Mara TynanBeth N. PeshkinMarc D. Schwartz Epidemiology 01 January 2020 Pages: 177 - 185
Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study Song YaoCecile A. LaurentMarilyn L. Kwan Epidemiology 07 January 2020 Pages: 187 - 195
Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy Audree B. TadrosTracy-Ann MooMonica Morrow Epidemiology 14 January 2020 Pages: 197 - 205
Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients Oluwadamilola M. FayanjuYi RenE. Shelley Hwang Epidemiology 20 January 2020 Pages: 207 - 217
Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence Catherine LeeDevon K. CheckLaurel A. Habel Epidemiology 23 January 2020 Pages: 219 - 226
Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age Jennifer K. PlichtaSamantha M. ThomasRachel A. Greenup Epidemiology 24 January 2020 Pages: 227 - 235
The novel TP53 3′-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection Feng ZengJianfu HengJun Wang Epidemiology 25 January 2020 Pages: 237 - 245
Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer Michael RoseHenry SvenssonJonas Manjer Epidemiology Open access 27 January 2020 Pages: 247 - 256
Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer Ximena GarcíaAndrés ElíaCaroline A. Lamb Brief Report 16 January 2020 Pages: 257 - 263
RE: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort Gianluca LopezNicola Fusco Letter to the Editor 16 January 2020 Pages: 265 - 266
Nationwide prevalence and trends of acute cardiovascular and cerebrovascular events among adult breast cancer survivors with a history of radiation therapy Snehal BansodRupak Desai Letter to the Editor 22 January 2020 Pages: 267 - 268
